Related Experiment Video
Updated: Jun 6, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src
Patricia A Eisenach1, Christian Roghi, Marton Fogarasi
1University of Cambridge, Department of Oncology, Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Abstract:
Membrane-type-1 matrix metalloproteinase (MT1-MMP) is a zinc-dependent type-I transmembrane metalloproteinase involved in pericellular proteolysis, migration and invasion, with elevated levels correlating with a poor prognosis in cancer. MT1-MMP-mediated transcriptional regulation of genes in cancer cells can contribute to tumour growth, although this is poorly understood at a mechanistic level. In this study, we investigated the mechanism by which MT1-MMP regulates the expression of VEGF-A in breast cancer cells. We discovered that MT1-MMP regulates VEGFR-2 cell surface localisation and forms a complex with VEGFR-2 and Src that is dependent on the MT1-MMP hemopexin domain and independent of its catalytic activity. Although the localisation of VEGFR-2 was independent of the catalytic and intracellular domain of MT1-MMP, intracellular signalling dependent on VEGFR-2 activity leading to VEGF-A transcription still required the MT1-MMP catalytic and intracellular domain, including residues Y573, C574 and DKV582. However, there was redundancy in the function of the catalytic activity of MT1-MMP, as this could be substituted with MMP-2 or MMP-7 in cells expressing inactive MT1-MMP. The signalling cascade dependent on the MT1-MMP-VEGFR-2-Src complex activated Akt and mTOR, ultimately leading to increased VEGF-A transcription.
Insights
Membrane-type-1 matrix metalloproteinase (MT1-MMP) regulates VEGF-A transcription in breast cancer. This involves a complex with VEGFR-2 and Src, impacting cell signaling and tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Membrane-type-1 matrix metalloproteinase (MT1-MMP) is crucial for cancer cell migration and invasion.
- Elevated MT1-MMP levels indicate a poor cancer prognosis.
- The precise mechanisms of MT1-MMP's transcriptional regulation in cancer are not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which MT1-MMP regulates VEGF-A expression in breast cancer cells.
- To investigate the role of MT1-MMP in cell surface localization of VEGFR-2.
- To identify the specific domains and activities of MT1-MMP involved in VEGF-A transcription.
Main Methods:
- Investigated MT1-MMP's interaction with VEGFR-2 and Src in breast cancer cells.
- Assessed the dependency of complex formation and VEGFR-2 localization on MT1-MMP domains and activity.
- Analyzed the downstream signaling cascade, including Akt and mTOR activation, leading to VEGF-A transcription.
Main Results:
- MT1-MMP forms a complex with VEGFR-2 and Src, dependent on its hemopexin domain but independent of its catalytic activity.
- VEGFR-2 cell surface localization is independent of MT1-MMP's catalytic and intracellular domains.
- VEGF-A transcription requires MT1-MMP's catalytic and intracellular domains, with functional redundancy from MMP-2 or MMP-7.
- The MT1-MMP-VEGFR-2-Src complex activates Akt and mTOR, promoting VEGF-A transcription.
Conclusions:
- MT1-MMP plays a critical role in regulating VEGF-A transcription through a complex involving VEGFR-2 and Src.
- Both the hemopexin domain and catalytic activity of MT1-MMP are essential for this process, albeit through distinct mechanisms.
- This pathway contributes to tumor growth by increasing VEGF-A expression in breast cancer.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Matrix Metalloproteases in Degradation of ECM
A...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

